Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →
← Back to NAICS Codes
NAICS Code· 325413

NAICS 325413: In-Vitro Diagnostic Substance Manufacturing

This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices. Cross-References.Show more

NAICS 325413 – In-Vitro Diagnostic Substance Manufacturing encompasses the production of reagents, kits, calibrators, controls, and other chemical or biological substances used in laboratory-based diagnostic testing. These products enable the detection, measurement, or monitoring of physiological conditions, infectious agents, biomarkers, and genetic markers in clinical specimens such as blood, urine, and tissue.

26
Active Contracts
$196.3M
Total Obligations (12mo)
1.2K
Awarded Contracts (12mo)
175
Contractors Awarded (12mo)
1
Median Bidders per Award
-74.1%
YoY Growth

Industry Spending Overview

Federal obligations, top contractors and agencies, and related industry codes for NAICS 325413.

AI Industry Description

NAICS 325413 – In-Vitro Diagnostic Substance Manufacturing encompasses the production of reagents, kits, calibrators, controls, and other chemical or biological substances used in laboratory-based diagnostic testing. These products enable the detection, measurement, or monitoring of physiological co...

NAICS 325413 – In-Vitro Diagnostic Substance Manufacturing encompasses the production of reagents, kits, calibrators, controls, and other chemical or biological substances used in laboratory-based diagnostic testing. These products enable the detection, measurement, or monitoring of physiological conditions, infectious agents, biomarkers, and genetic markers in clinical specimens such as blood, urine, and tissue. Manufactured under strict quality control standards compliant with CLIA, FDA, and ISO 13485, these in-vitro diagnostic substances are critical to clinical decision-making, public health surveillance, and point-of-care testing infrastructure. In government contracting, this sector supports military medical readiness, veteran healthcare delivery, and biodefense preparedness programs by supplying essential components for automated clinical analyzers and laboratory information systems. Top contractors in this space include MARATHON MEDICAL CORPORATION and TERUMO MEDICAL CORP, both established life sciences manufacturers with deep expertise in sterile, GMP-compliant production of diagnostic reagents. These firms operate as large primes with extensive regulatory compliance capabilities, often serving as sole-source or limited-source suppliers due to the technical complexity and validation requirements of diagnostic substances. The Department of Veterans Affairs and the Department of Defense are the primary federal buyers, procuring these substances to support clinical laboratories in VA medical centers and military treatment facilities. Demand is driven by routine patient diagnostics, deployable medical unit requirements, and biodefense initiatives focused on rapid pathogen identification and health threat monitoring. The competitive landscape is characterized by high regulatory barriers, stringent validation protocols, and long procurement cycles, favoring manufacturers with proven quality systems and established FDA clearances. Opportunities exist for contractors with expertise in assay development, cold-chain logistics, and rapid scale-up of diagnostic materials to meet surge requirements during public health emergencies.

Small Business Size Standard

The SBA threshold that decides who can bid NAICS 325413 work as a small business.

1,250 employees
Applies to the whole industry code

The SBA cap for this NAICS (13 CFR 121.201). A business at or under it can self-certify as small for work in this code, which is what makes it eligible for a small-business set-aside. The cap is set per NAICS, so the same company can be small in one code and not in another.

13 CFR 121.201, effective January 1, 2026. The SBA revises the table roughly once a year.

Top Contractors

Companies with the highest total award value under NAICS 325413, ranked by dollars won.

Top Agencies

Federal agencies directing the most contract spending toward NAICS 325413.

Department Of Veterans Affairs631 awards$125.6M
Department Of Defense400 awards$29.4M
Department Of Health And Human Services126 awards$13.5M
W40M Mrco Pacific6 awards$6.9M
Department Of Agriculture23 awards$4.9M
W40M MRC0 West5 awards$4.7M
W40M USA Hca1 award$2.4M
262-NETWORK Contract Office 22 (36C262)3 awards$2.4M
W40M Mrco Europe2 awards$1.9M
261-NETWORK Contract Office 21 (36C261)1 award$1.1M

Competition

How many companies historically bid on federal awards in NAICS 325413, from bidder counts reported on USAspending.

Usually Single-Bid

Half or more of reported awards drew exactly one bidder, usually a sign of incumbent-held work rather than an open field. · 77,836 reported awards

Median Bidders

1

Per reported award, all-time

Single-Bid Awards

88%

Share of reported awards with one bidder

10+ Bidder Awards

1%

Share of reported awards with 10+ bidders

Reported Awards

77,836

89% of 87,609 total awards

Bidder Count Distribution by Fiscal Year

Share of reported awards in each bidder-count bracket per federal fiscal year.

How this code compares up the NAICS hierarchy. Parent cohorts pool every code under their prefix, so they are the steadier baseline when a 6-digit sample is thin.

Industry FamilyCompetitionMedian BiddersSingle-BidBidder MixReported Awards
325413This Code
In-Vitro Diagnostic Substance Manufacturing
Usually Single-Bid188%
77,83689% of 87,609
32541NAICS Industry
Moderate Competition434%
767,34430% of 2,563,626
3254Industry Group
Pharmaceutical and Medicine Manufacturing
Moderate Competition434%
767,34430% of 2,563,626
325Subsector
Moderate Competition336%
1,584,19136% of 4,451,964
32Sector
Manufacturing
Moderate Competition331%
3,145,73729% of 10,805,773

Bidder counts reported on past federal awards in this NAICS (USAspending). An open opportunity has no bidders yet, so this is the historical norm for similar work, not a fact about this solicitation. Not all awards report bidder counts, and fewer bidders often means incumbent-held work rather than an easier win. Federal reporting of bidder counts fell from ~96% of awards (FY2016) to ~30% (FY2018 onward); the chart shows shares of reported awards, and washed-out stretches mark years with fewer than 30 of them.

Related NAICS Codes

Industries similar to In-Vitro Diagnostic Substance Manufacturing, by shared sector, subsector, and industry group.

Explore contracts across multiple NAICS codes Browse all NAICS Codes

Dotted
NAICS 325413 FAQ

Frequently Asked Questions

NAICS code 325413 covers In-Vitro Diagnostic Substance Manufacturing. This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices. Cross-References.

Recently Posted in In-Vitro Diagnostic Substance Manufacturing

NAICS: 325413
New
Federal
6550 Microbiology Testing Media for MRSA and VRE, purchase order for Microbiology Media
Solicitation # 36C26027Q0069
The Department of Veterans Affairs, through Network Contracting Office 20, is soliciting bids for a total small business set-aside contract to provide microbiology testing media for the Seattle Division Microbiology Department. The required supplies include MRSA Select II and VRE Select Kits, or equivalents, which are mandatory for identifying pathogenic organisms in veteran patients. The contract follows a base year from November 1, 2026, to October 31, 2027, with four subsequent one-year option periods, extending the total period of performance through October 31, 2031. Deliveries are to be made on an as-needed basis to the Seattle VAMC VA Puget Sound Healthcare System Warehouse 90D under FOB Destination terms. Award will be granted to the responsible offeror determined to be most advantageous based on price and other factors, including the capability to deliver monthly orders, adherence to the price schedule, provision of Safety Data Sheets, and assurance that media is test-worthy upon delivery. Offerors must submit a technical compliance statement limited to one page and complete a five-year price schedule. Payment will be processed via electronic submission through the VA's Invoice Presentation and Payment System or an EDI-conforming system with net 30-day terms. The solicitation incorporates various FAR and VAAR clauses, including specific deviations regarding DEI discrimination and security prohibitions.
260-NETWORK Contract Office 20 (36C260)

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 325413
Awarded
DIBBS
CONTROL, HEMOGLOBIN
Solicitation # SPE2DS-26-T-483E
Solicitation SPE2DS-26-T-483E is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Hemotrol Duo Normal hemoglobin controls, identified by NSN 6550-01-722-4549. The requirement is for three boxes, with each box containing two 1ML units. These matrix-based purified hemolysate solutions must be optimized for use with HemoCue HB 301 and HB 801 systems. Delivery is required within 20 days after receipt of order to the USS George Washington CVN 73 at FPO AP 96607. The product is subject to strict quality and storage mandates, requiring refrigeration between 2 to 8 degrees Celsius. It must have a non-extendable shelf life of 24 months, with no more than three months elapsed from the date of manufacture to the date of government delivery. Packaging must be commercial and compliant with Medical Marking Standard No. 1, which supersedes MIL-STD-129. All labels must clearly state the contract number, lot number, and dates of manufacture and expiration. Offerors must submit quotes via the DIBBS system by October 5, 2026. Technical evaluations for alternate parts require a complete data package, and the successful bidder must provide a Safety Data Sheet prior to award to be deemed responsible. The contract incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, Berry Amendment, and the safeguarding of covered defense information. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow system.
Defense Logistics Agency

POSTED

5 days ago

DEADLINE

N/A
View Details

Win Contracts in In-Vitro Diagnostic Substance Manufacturing

Get AI-powered intelligence on NAICS 325413 procurement

Real-time contract opportunities for NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing)

AI-powered matching based on your business capabilities and past performance

Competitive analysis of contractors winning awards in this industry

Automated alerts when new opportunities are posted

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS